From: Framing overdiagnosis in breast screening: a qualitative study with Australian experts
Participants 33 (Brackets contain number of experts who were invited but did not-participate; 13) | |
---|---|
Professional role* | Clinicians^ 15 (3) |
 | • Oncologists 3 (1) |
 | • Surgeons 4 (0) |
 | • Breast physicians 1 (2) |
 | • Radiologists 2 (0) |
 | • Radiation oncologists 2 (0) |
 | • Pathologists 3 (0) |
 | • Others [not otherwise specified; NOS)] 0 (1) |
 | Non-clinical researchers 14 (3) |
 | • Epidemiologists/biostatisticians 9 (1) |
 | • Others [NOS] 5 (1) |
 | Administrators/managers 6 (2) |
 | Advocacy leaders 6 (7) |
 | • Consumers working in advocacy 3 (6) |
• Clinicians/researchers working in advocacy 3 (1) | |
Public stance on breast screening+ | Supportive 16 (9) |
Mostly supportive# 3 (1) | |
Critical 6 (0) | |
Unknown to researchers 8 (3) |